tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
ZVRA
Zevra Therapeutics
RESEARCH TOOLSreports
Want to see ZVRA full AI Analyst Report?

Zevra Therapeutics (ZVRA) Ratios

1,063 Followers

Zevra Therapeutics Ratios

ZVRA's free cash flow for Q1 2026 was $0.94. For the 2026 fiscal year, ZVRA's free cash flow was decreased by $ and operating cash flow was $0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.89 5.68 2.53 1.18 7.72
Quick Ratio
 4.84 5.63 2.47 0.85 7.72
Cash Ratio
 2.03 1.59 0.99 0.58 5.45
Solvency Ratio
 1.74 0.67 -0.72 -0.41 -0.64
Operating Cash Flow Ratio
 0.27 -0.04 -2.05 -0.45 -1.56
Short-Term Operating Cash Flow Coverage
 31.44 0.00 0.00 -0.89 -4.02
Net Current Asset Value
$ 157.19M$ 92.93M$ -52.43M$ -23.52M$ 52.61M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.22 0.34 0.25 0.16
Debt-to-Equity Ratio
 <0.01 0.41 1.52 0.71 0.25
Debt-to-Capital Ratio
 <0.01 0.29 0.60 0.41 0.20
Long-Term Debt-to-Capital Ratio
 <0.01 0.29 0.60 0.08 0.15
Financial Leverage Ratio
 1.35 1.84 4.49 2.79 1.54
Debt Service Coverage Ratio
 20.63 11.94 -12.48 -1.11 -5.11
Interest Coverage Ratio
 -11.34 -0.53 -11.84 -33.05 -127.06
Debt to Market Cap
 <0.01 0.12 0.15 0.18 0.11
Interest Debt Per Share
 0.09 1.29 1.46 1.28 0.55
Net Debt to EBITDA
 -0.89 <0.01 -0.35 -0.02 1.83
Profitability Margins
Gross Profit Margin
85.51%84.52%68.59%89.28%97.82%
EBIT Margin
84.58%88.90%-350.62%-162.22%-260.51%
EBITDA Margin
86.85%92.71%-323.56%-158.56%-251.22%
Operating Profit Margin
-39.86%-3.98%-368.47%-180.63%-418.91%
Pretax Profit Margin
109.09%81.41%-381.76%-167.69%-263.80%
Net Profit Margin
101.58%78.17%-446.85%-167.69%-263.48%
Continuous Operations Profit Margin
101.58%78.17%-446.85%-167.69%-263.48%
Net Income Per EBT
93.12%96.02%117.05%100.00%99.88%
EBT Per EBIT
-273.64%-2047.67%103.61%92.83%62.97%
Return on Assets (ROA)
44.59%29.23%-59.23%-26.72%-23.21%
Return on Equity (ROE)
81.34%53.82%-266.00%-74.44%-35.64%
Return on Capital Employed (ROCE)
-21.05%-1.72%-60.39%-50.30%-41.20%
Return on Invested Capital (ROIC)
-19.57%-1.65%-60.22%-36.25%-39.20%
Return on Tangible Assets
46.39%30.42%-101.03%-46.80%-23.21%
Earnings Yield
21.20%16.79%-27.35%-19.83%-16.91%
Efficiency Ratios
Receivables Turnover
 5.53 4.58 2.25 1.58 1.22
Payables Turnover
 0.00 6.65 0.57 0.21 0.06
Inventory Turnover
 7.67 9.47 3.76 0.12 0.00
Fixed Asset Turnover
 80.61 62.59 23.31 18.00 5.70
Asset Turnover
 0.44 0.37 0.13 0.16 0.09
Working Capital Turnover Ratio
 0.67 0.90 0.72 0.58 0.11
Cash Conversion Cycle
 113.55 63.39 -384.04 1.48K -5.64K
Days of Sales Outstanding
 65.96 79.73 162.45 230.97 298.11
Days of Inventory Outstanding
 47.59 38.53 96.95 2.98K 0.00
Days of Payables Outstanding
 0.00 54.88 643.44 1.73K 5.94K
Operating Cycle
 113.55 118.27 259.40 3.22K 298.11
Cash Flow Ratios
Operating Cash Flow Per Share
 0.22 -0.03 -1.51 -0.95 -0.54
Free Cash Flow Per Share
 0.21 -0.04 -1.51 -0.95 -0.55
CapEx Per Share
 0.01 0.02 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.94 1.52 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 16.56 -1.91 0.00 -113.29 -201.26
Capital Expenditure Coverage Ratio
 16.56 -1.91 0.00 -113.29 -201.26
Operating Cash Flow Coverage Ratio
 11.13 -0.03 -1.16 -0.77 -1.00
Operating Cash Flow to Sales Ratio
 0.10 -0.02 -2.95 -1.22 -1.84
Free Cash Flow Yield
2.02%-0.49%-18.06%-14.57%-11.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 4.72 5.95 -3.66 -5.04 -5.91
Price-to-Sales (P/S) Ratio
 4.85 4.65 16.34 8.46 15.58
Price-to-Book (P/B) Ratio
 2.85 3.20 9.72 3.75 2.11
Price-to-Free Cash Flow (P/FCF) Ratio
 49.43 -203.69 -5.54 -6.86 -8.42
Price-to-Operating Cash Flow Ratio
 45.89 -310.13 -5.54 -6.92 -8.46
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.04 -0.05 -0.08 0.09
Price-to-Fair Value
 2.85 3.20 9.72 3.75 2.11
Enterprise Value Multiple
 4.69 5.03 -5.40 -5.35 -4.37
Enterprise Value
 498.48M 496.39M 412.25M 232.93M 111.62M
EV to EBITDA
 4.69 5.03 -5.40 -5.35 -4.37
EV to Sales
 4.08 4.66 17.46 8.48 10.98
EV to Free Cash Flow
 41.56 -204.02 -5.92 -6.89 -5.93
EV to Operating Cash Flow
 39.05 -310.63 -5.92 -6.95 -5.96
Tangible Book Value Per Share
 3.34 2.60 -0.74 -0.34 2.18
Shareholders’ Equity Per Share
 3.52 2.80 0.86 1.74 2.18
Tax and Other Ratios
Effective Tax Rate
 0.07 0.04 -0.17 0.00 <0.01
Revenue Per Share
 2.09 1.92 0.51 0.77 0.29
Net Income Per Share
 2.13 1.50 -2.28 -1.30 -0.78
Tax Burden
 0.93 0.96 1.17 1.00 1.00
Interest Burden
 1.29 0.92 1.09 1.03 1.01
Research & Development to Revenue
 0.11 0.12 1.78 1.45 1.95
SG&A to Revenue
 0.64 0.73 2.32 0.00 1.51
Stock-Based Compensation to Revenue
 0.08 0.12 0.63 0.22 0.42
Income Quality
 0.10 -0.02 0.66 0.73 0.45
Currency in USD